A history of cancer does not produce a simple yes-or-no answer about platelet-rich plasma injections. The type of cancer, whether it is active or in remission, current treatment and the proposed injection site all matter. PRP is an elective treatment: if the clinical situation is uncertain, the injection should wait until the relevant specialists have agreed a safe plan.
This guide concerns PRP for musculoskeletal problems, such as joint or tendon symptoms. It is not advice to use PRP to treat cancer or to manage the effects of cancer treatment. Evidence from joint injections cannot automatically be applied to scalp, facial or other uses.
Can you have PRP after cancer?
PRP is prepared from your own blood, but "autologous" does not mean that every medical circumstance is suitable. The preparation contains platelets and signalling substances. Cancer history can change the risk assessment, and some treatments can affect blood counts, infection risk or healing. [1]
A 2025 multidisciplinary GRIIP consensus specifically addresses PRP in people with infectious, oncological and blood disorders. It is useful because it distinguishes active disease, remission and a history considered cured instead of treating every past cancer as the same situation. Most of its recommendations are based on limited evidence and expert opinion, not large trials proving safety in every cancer subgroup. [1]
Ask The London PRP Clinic, part of The Wellness, about a suitability assessment. Mention your cancer history before arranging an injection appointment, not only when you arrive.
What does the consensus say about active cancer?
For solid cancers under investigation or considered active, the consensus recommends against PRP, apart from exceptional situations discussed with the oncologist. It also recommends avoiding injection near benign or malignant tumours and certain local abnormal tissue conditions. [1]
This is a precautionary clinical recommendation. It is not proof that a particular injection will cause cancer to spread, nor a reason to dismiss a new painful area as ordinary arthritis. If a joint, bone or soft-tissue symptom is unexplained, establishing the diagnosis comes before choosing an injection.
Cancer treatment should not be paused or altered to create a window for PRP without the treating team's advice. A cosmetic or elective musculoskeletal appointment should fit the oncology plan, not compete with it.
Is remission different from active disease?
Yes. For non-metastatic solid cancer considered in remission by the oncologist after treatment, the consensus allows PRP to be considered. For a history the oncologist considers cured, it also does not impose a blanket prohibition. These statements are not guarantees that PRP will be appropriate or effective for the person's joint problem. [1]
Where metastatic solid cancer is considered in remission, the consensus requires oncologist agreement. That distinction is important: a general statement that someone is "all clear" may not capture the clinical history or current treatment.
Rather than asking for a vague permission letter, give the treating clinician a clear description of the planned treatment, site and reason, with the injection clinician's contact details. The two teams can then decide what information is needed.
What about blood cancers or abnormal blood counts?
Blood disorders require their own assessment. The same consensus distinguishes active or unstable haematological malignancy from disease in remission or considered cured, and identifies situations needing haematologist input. A significant blood-count abnormality should be investigated before PRP. [1]
Do not use a platelet number alone to self-clear for treatment. Bleeding risk, platelet function, medicines, anaemia, infection and the underlying diagnosis may all matter. A normal count also does not settle every procedural risk.
If you have recent full blood count results, bring the original report. If no recent tests are available, the clinician should decide whether testing is needed for your circumstances; an expensive general health panel is not a substitute for a focused safety question.
Does this evidence apply to PRP for hair or skin?
Not automatically. The GRIIP group deliberately limited its recommendations to musculoskeletal conditions because it did not include the relevant specialist expertise for all other PRP uses. Extending those statements to hair or skin treatments without qualification would go beyond the source. [1]
If your goal is hair restoration after cancer treatment, the cause and pattern of hair loss, current oncology medicines and the timing of recovery need a separate discussion. This article does not establish that scalp PRP is safe or effective in that setting. Ask the treating specialist and an appropriately qualified clinician before committing to treatment.
How should a useful consultation be organised?
Bring your diagnosis and treatment summary, current medicines, relevant blood results and the oncology team's current assessment. Explain what you want to improve: pain, walking tolerance, sport or another practical goal. The clinician should first confirm that the musculoskeletal diagnosis is correct and that established alternatives have been considered.
A useful plan records whether specialist advice is needed, why PRP is being considered, what uncertainty remains and when the decision will be revisited. If PRP is not suitable, the appointment should still leave you with an appropriate route for the underlying problem.
Contact the clinic before booking a procedure to ask what records are needed and whether consultation, investigations and treatment are charged separately. There is no reason to pay for a treatment course before suitability is established.
When should a new symptom be assessed promptly?
New unexplained bone or joint pain, a new lump, persistent night pain or a marked change in symptoms deserves medical review, particularly with a cancer history. A hot swollen joint, fever or acute inability to bear weight needs urgent assessment. Do not assume that an old arthritis diagnosis explains a new problem.
If your oncology team has given you an urgent-contact plan, follow it. An elective PRP consultation is not a substitute for that service.
Questions patients often ask
Does PRP contain my own cancer cells? This cannot be answered for an individual from a general article. The consensus discusses theoretical disease-related risks and uses a precautionary approach; it does not offer a screening test that makes every preparation safe.
How many years after cancer must I wait? There is no single interval in the cited consensus that safely applies to every cancer and treatment. Current disease status and specialist assessment matter more than an invented universal waiting period.
Can the injection clinician overrule my oncologist? A safe elective plan should be coordinated, not based on conflicting advice left for you to reconcile.
Will PRP rebuild a damaged joint? Do not treat symptom improvement as proof of structural regeneration. The separate evidence for your diagnosis must be discussed honestly.
Discuss suitability with The London PRP Clinic. The right outcome may be an alternative treatment or a decision to wait.
Ask the team on WhatsApp, call +44 20 3951 3429 or email team@thewellnesslondon.com to discuss an appropriate consultation.
Evidence and further reading
- Indications and contraindications to PRP injections in musculoskeletal diseases with infectious, oncological and haematological comorbidities: 2025 GRIIP formal consensus. Multidisciplinary consensus; most recommendations are Grade D expert opinion, with limited direct clinical safety evidence. Its scope is musculoskeletal PRP, not all regenerative or cosmetic treatments.
Evidence checked 31 October 2026. This article cannot provide individual oncology clearance or a guarantee of treatment safety.
Contact The London PRP Clinic to establish the right assessment before booking treatment.